---
schema_version: "secwatch.filing_event.v1"
accession: "0000200406-26-000076"
form_type: "8-K"
ticker: "JNJ"
cik: "0000200406"
company_name: "JOHNSON & JOHNSON"
filed_at: "2026-04-14T23:59:59+00:00"
generated_at: "2026-05-15T06:27:41.295984+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# JNJ Q1 adj. EPS $2.70 (down 1.4% YoY); raises dividend 3.1% to $1.34/qtr

## Summary
- Q1 revenue $24.06B, up 9.9% YoY (operational growth 6.4%, currency 3.5%).
- GAAP net earnings $5.24B ($2.14 diluted EPS) vs $11.0B ($4.54) in Q1 2025, down 52% due to prior-year other income.
- Adjusted net earnings $6.61B ($2.70 diluted EPS) vs $6.71B ($2.77), down 1.4% YoY.
- Dividend increased 3.1% to $1.34 per quarter ($5.36 annual), marking 64th consecutive annual increase; payable June 9, 2026 to record May 26.
- Innovative Medicine segment sales $15.4B (+11.2%); MedTech $8.6B (+7.7%).

## SEC filing metadata
- accession: 0000200406-26-000076
- form_type: 8-K
- ticker: JNJ
- cik: 0000200406
- company_name: JOHNSON & JOHNSON
- filed_at: 2026-04-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/200406/000020040626000076/0000200406-26-000076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/200406/000020040626000076/jnj-20260414.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000200406-26-000076
- JSON: https://secwatch.observer/filing/0000200406-26-000076.json
- Plain text: https://secwatch.observer/filing/0000200406-26-000076.txt

## Key facts
- Earnings Releases
  JOHNSON & JOHNSON reported first quarter ended March 29, 2026 results: revenue $24,062, net income $5,235, EPS $2.14.
  - Period: first quarter ended March 29, 2026
  - Revenue: $24,062
  - Net income: $5,235
  - EPS: $2.14
  - Result: reported results
  source text: 5,110 14.5 2.7 11.8 Western Hemisphere excluding U.S. 1,293 1,167 10.8 2.5 8.3 Asia-Pacific, Africa 3,591 3,311 8.5 6.1 2.4 International 10,732 9,588 11.9 3.9 8.0 Worldwide $24,062 21,893 9.9 % 6.4 3.5 Note: Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely. Johnson & Johnson and subsidiaries
  evidence_url: https://www.sec.gov/Archives/edgar/data/200406/000020040626000076/0000200406-26-000076-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.